Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China

• DOI: 10.21037/atm.2020.04.20
• Publication Date: 2020-04-30T05:25:07Z
• Authors: Yongpo Jiang; Susu He; Chao Zhang; Xiaodan Wang; Xi Chen; Yingying Jin; Zebao He; Minjie Cai; Zongmei Lin; Lingjun Ying; Jianli Mou; Haihong Zhao; Ronghai Lin; Sheng Zhang; Xiaomai Wu; Haixiao Chen; Dongqing Lv
• Keywords: Coronavirus; Oseltamivir

The number of patients with pneumonia stemming from the 2019 novel coronavirus (COVID-19) infection has increased rapidly. However, clinical characteristics discharged remain little known. Here, we attempt to describe and treatment experiences cases Taizhou, China.A total 60 COVID-19-infected who were Taizhou Enze Medical Center (Group), January 31, 2020, February 16, included in analysis. discharge criteria based on New Coronavirus Pneumonia Prevention Control Program (Fifth Edition, China).Of patients, median age was 41 years, 58.3% male. Only 13.3% identified as having severe pneumonia. All received combined antiviral admission, including β-interferon, lopinavir/tonavir, Abidol oseltamivir. conditions gamma globulin hormone therapy. No had endotracheal intubation or died. duration symptom onset hospitalization 3 (range, 0-15) days. COVID-19 shedding 14 5-26) days, hospital stay 15 7-23) days.Early therapy comprehensive are key outcome for pneumonia, especially those pneumonia.ChiCTR2000029866.